These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6266808)

  • 41. Systemic challenge with endotoxin stimulates corticotropin-releasing hormone and arginine vasopressin secretion into hypophyseal portal blood: coincidence with gonadotropin-releasing hormone suppression.
    Battaglia DF; Brown ME; Krasa HB; Thrun LA; Viguié C; Karsch FJ
    Endocrinology; 1998 Oct; 139(10):4175-81. PubMed ID: 9751497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of angiotensin II on release of CRH and AVP from hypothalamus during acute hypoxia.
    Wu Y; Du JZ
    Acta Pharmacol Sin; 2000 Nov; 21(11):1035-8. PubMed ID: 11501060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin.
    Plotsky PM; Bruhn TO; Vale W
    Endocrinology; 1984 Oct; 115(4):1639-41. PubMed ID: 6332731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively.
    Link H; Dayanithi G; Föhr KJ; Gratzl M
    Endocrinology; 1992 Apr; 130(4):2183-91. PubMed ID: 1312449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status.
    De Goeij DC; Dijkstra H; Tilders FJ
    Endocrinology; 1992 Aug; 131(2):847-53. PubMed ID: 1322285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution and characterization of corticotropin-releasing factor and arginine vasopressin in rat hypothalamic nuclei.
    Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T
    Neuroendocrinology; 1982 Jan; 34(1):32-7. PubMed ID: 6977102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotropin-releasing factor and arginine vasopressin.
    Watanabe T; Orth DN
    Endocrinology; 1987 Sep; 121(3):1133-45. PubMed ID: 3040378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner.
    Canny BJ; Funder JW; Clarke IJ
    Endocrinology; 1989 Nov; 125(5):2532-9. PubMed ID: 2676486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasopressin gene products are colocalised with corticotrophin-releasing factor within neurosecretory vesicles in the external zone of the median eminence of the Japanese macaque monkey (Macaca fuscata).
    Otubo A; Kawakami N; Maejima S; Ueda Y; Morris JF; Sakamoto T; Sakamoto H
    J Neuroendocrinol; 2020 Aug; 32(8):e12875. PubMed ID: 32715549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway.
    Kakui N; Kitamura K
    Endocrinology; 2007 Jun; 148(6):2854-62. PubMed ID: 17363455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors.
    Koch B; Lutz-Bucher B
    Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Release of corticotropin and corticotropin-releasing factors from rat posterior pituitary in vitro.
    Bény JL; Baertschi AJ
    Neuroendocrinology; 1980; 30(2):108-12. PubMed ID: 6243758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neonatal facilitation of stress-induced adrenocorticotropin secretion by prior stress: evidence for increased central drive to the pituitary.
    Walker CD; Dallman MF
    Endocrinology; 1993 Mar; 132(3):1101-7. PubMed ID: 8382596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corticotropin-releasing factor and vasopressin production in the rat pituitary tumor 7315a: biochemical and immunohistochemical studies.
    Morano MI; Estivariz FE
    Cancer Res; 1989 May; 49(10):2755-60. PubMed ID: 2540907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats.
    Whitnall MH; Smyth D; Gainer H
    Neuroendocrinology; 1987 May; 45(5):420-4. PubMed ID: 3295576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.
    Rivier C; Vale W
    Fed Proc; 1985 Jan; 44(1 Pt 2):189-95. PubMed ID: 2981740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C
    Neuroendocrinology; 1977; 23(3):181-92. PubMed ID: 197442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of serotonin agonist 1-(trifluoromethylphenyl)-piperazine on corticotropin releasing factor and arginine vasopressin in rat hypothalamic nuclei.
    Hashimoto K; Ohno N; Murakami K; Kageyama J; Aoki Y; Takahara J
    Endocrinol Jpn; 1982 Jun; 29(3):383-8. PubMed ID: 6293810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of vasopressin in corticotropin-releasing effect of hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C; Briaud B
    Neuroendocrinology; 1980; 30(3):178-82. PubMed ID: 6245385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.